From: Mesenchymal stromal cell biotherapy for Parkinson’s disease premotor symptoms
Symptom | Clinical intervention | Potential biotherapy | Other recommendation | ||
---|---|---|---|---|---|
Risk | Delivery path | ||||
Anxiety | Benzodiazepines (diazepam, lorazepam) | Lead to chronic stress that can worsen NMS | - | - | Further gut-brain axis modulation (gut microbiota with Lactobacillus plantarum PS128) |
Cognitive impairment | Donepezil, galantamine, rivastigmine | Development of dementia | BMSC | Intravenous infusion | Increased adverse events (accidental falls, cognitive deterioration) with antipsychotics |
Depression | Cognitive behavioral therapy, pramipexole, repetitive transcranial magnetic stimulation, venlafaxine | Prolongation of the Q-T interval when citalopram exceeds 20 mg in patients over 60 years old | NSC | Intravenous infusion | Sertraline, paroxetine, fluoxetine, citalopram with mild adverse reactions, contraindicated with monoamine oxidase B inhibitors MAO-BI. ECG monitoring is recommended Hippocampal/NSC neurogenic compound NSI-189 |
Psychosis | Clozapine, pimavanserin | - | UC-MSC | Intravenous infusion | Regular blood routine monitoring is required |
Impulse control disorder | Cognitive behavioral therapy | - | - | - | Dopamine agonist withdrawal syndrome should be monitored |
Indifference | Piribedil | Comorbid depression, caregiver burden | - | - | Monitor patients for apathy after subthalamic nucleus deep brain stimulation surgery |
Orthostatic hypotension | Droxidopa, fludrocortisone, midodrine | - | - | - | Moderate the use of diuretics, antidepressants, etc |
Chronic constipation | Polyethylene glycol, probiotics/prebiotic fiber | - | Fecal microbiota transplantation | Upper gastrointestinal tract via nasoenteric tubes | Gut microbiota with probiotic supplements [8] |
Anorexia, nausea, vomiting | Domperidone | - | - | - | Electrocardiogram needs to be monitored |
Salivation | Ultrasound-guided botulinum toxin type A/B the injection to parotid gland/ submandibular gland | - | - | - | Chewing |
Urinary dysfunction | Solifenacin | - | Myoblasts | Intrasphincteric injection | Anticholinergic (dry mouth, constipation) and non-cholinergic (indigestion, dizziness, headache) adverse reactions |
Erectile dysfunction | Sildenafil | - | ASC | Intravenous infusion | Monitor orthostatic hypotension |
Insomnia | Amantadine, eszopiclone, melatonin | - | - | - | Moderate the use of anti-PD drugs; continuous positive airway pressure for obstructive sleep apnea; further gut-brain axis modulation (gut microbiota with Lactobacillus fermentum PS150) |
RBD | Clonazepam, melatonin | - | - | - | Moderate the use of SSRIs, SNRIs, TCAs, MAO-BI, or benzodiazepines |
Pain | Opioids | - | - | - | Monitor constipation, gut microbiota with probiotic supplements, MSC-derived exosomes injection |
Fatigue | Rasagiline | - | - | - | - |